Table 1.
Demographic information of the study.
| Control | RP | Control vs. intact | Control vs. defect | Defect vs. intact | ||
|---|---|---|---|---|---|---|
| Macular defect | Macular intact | P value | P value | P value | ||
| Number | 25 | 8 | 9 | |||
| Sex (eye/patients) | ||||||
| Male | 10(10) | 8(4) | 9(5) | 0.674a | ||
| Female | 15(15) | 7(4) | 6(4) | |||
| Eyes | 15 | 15 | ||||
| Age, y | 51.0 ± 12.0 | 51.3 ± 12.4 | 49.0 ± 10.9 | 0.736 | 0.959 | 0.744 |
| Range | (28–66) | (32–60) | (37–57) | |||
| VA (log MAR) | 0 | 1.5(1.2–0.5) | 0.3 (0.32–0) | P = 0.112 | P < 0.001 | 0.014 |
| Snellen 20/20 | Snellen 20/1000 | Snellen 20/40 | ||||
VA means vision acuity, P < 0.05 was considered as significant, ANONA for age, a for Chi-square test, and the VA analysis in different groups were compared by Kruskal–Wallis H test.